You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

diaminopyridine

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Congenital Myasthenic Syndrome Trial in Sacramento (3,4-Diaminopyridine)

Available
  • Congenital Myasthenic Syndrome
  • Sacramento, California
    University of California, Davis Medical Center
Apr 18, 2022

Myasthenic Syndromes, Congenital Trial in Durham (3,4-diaminopyridine)

No longer available
  • Myasthenic Syndromes, Congenital
  • Durham, North Carolina
    Duke University Hospital
Jan 3, 2022

Lambert Eaton Myasthenic Syndrome Trial in Aurora (3, 4-Diaminopyridine)

Approved for marketing
  • Lambert Eaton Myasthenic Syndrome
  • 3, 4-Diaminopyridine
  • Aurora, Colorado
    University of Colorado
Sep 28, 2021

Brugada Syndrome Trial in Paris (3,4-Di-amino-Pyridine, )

Terminated
  • Brugada Syndrome
  • Paris, France
    Lariboisière University Hospital - Cardiology department
Dec 3, 2020

Myasthenic Syndromes, Congenital Trial in United States (amifampridine phosphate, Placebo)

Completed
Has Results
  • Myasthenic Syndromes, Congenital
  • amifampridine phosphate
  • Placebo
  • Los Angeles, California
  • +3 more
Mar 8, 2021

Muscular Atrophy, Spinal Trial in Milano (Amifampridine Phosphate, Placebo Oral Tablet)

Completed
Has Results
  • Muscular Atrophy, Spinal
  • Amifampridine Phosphate
  • Placebo Oral Tablet
  • Milano, Lombardy, Italy
    Neurological Institute Carlo Besta
May 28, 2021

Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenia (CM) Trial in Portland (3,4-diaminopyridine)

No longer available
  • Lambert-Eaton Myasthenic Syndrome (LEMS)
  • Congenital Myasthenia (CM)
  • Portland, Oregon
    Oregon Health & Science University
Dec 9, 2019

Lambert Eaton Myasthenic Syndrome Trial in Sacramento (3, 4 DAP)

No longer available
  • Lambert Eaton Myasthenic Syndrome
  • 3, 4 DAP
  • Sacramento, California
    University of California, Davis
Oct 28, 2019

Lambert-Eaton Myasthenic Syndrome Trial (3,4 diaminopyridine)

No longer available
  • Lambert-Eaton Myasthenic Syndrome
  • 3,4 diaminopyridine
  • (no location specified)
Jul 5, 2019

Muscle Weakness Trial in Lebanon (3-4 Diaminopyridine)

Terminated
Has Results
  • Muscle Weakness
  • 3-4 Diaminopyridine
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
May 1, 2019

Congenital Myasthenic Syndrome Trial in Los Angeles (Amifampridine Phosphate)

No longer available
  • Congenital Myasthenic Syndrome
  • Amifampridine Phosphate
  • Los Angeles, California
    UCLA
Dec 5, 2019

Episodic Ataxia Type 2 Trial in Los Angeles, Tampa, Rochester (4-Aminopyridine, Placebo)

Withdrawn
  • Episodic Ataxia Type 2
  • Los Angeles, California
  • +2 more
Nov 12, 2020

Walking Impairment, Multiple Sclerosis Trial in Canada, United States (ADS-5102, 137 mg, ADS-5102, 274 mg, Placebo)

Completed
Has Results
  • Walking Impairment
  • Multiple Sclerosis
  • ADS-5102, 137 mg
  • +2 more
  • Cullman, Alabama
  • +83 more
Dec 19, 2021

Lambert-Eaton Myasthenic Syndrome, Eaton-Lambert Myasthenic Syndrome Trial in United States (Continuous 3,4-DAP, Taper 3,4-DAP

Completed
Has Results
  • Lambert-Eaton Myasthenic Syndrome
  • Eaton-Lambert Myasthenic Syndrome
  • Continuous 3,4-DAP
  • Taper 3,4-DAP to Placebo
  • Sacramento, California
  • +6 more
Jul 7, 2017

Lambert Eaton Myasthenic Syndrome Trial in Worldwide (Amifampridine Phosphate, Placebo)

Completed
Has Results
  • Lambert Eaton Myasthenic Syndrome
  • Amifampridine Phosphate
  • Placebo
  • Birmingham, Alabama
  • +13 more
Jan 3, 2018

Lambert-Eaton Myasthenic Syndrome Trial in Cleveland (3,4 DAP)

No longer available
  • Lambert-Eaton Myasthenic Syndrome
  • 3,4 DAP
  • Cleveland, Ohio
    Cleveland Clinic Foundation
Jul 18, 2016

Botulism Trial in Amiens (3,4-diaminopyridine)

Completed
  • Botulism
  • Amiens, France
    CHU
Apr 27, 2016

Lambert-Eaton Myasthenic Syndrome Trial (3,4-diaminopyridine)

Completed
  • Lambert-Eaton Myasthenic Syndrome
  • (no location specified)
Mar 24, 2015

Non Arteritic Ischemic Optic Neuropathy Trial in Philadelphia (dalfampridine, Placebo)

Completed
  • Non Arteritic Ischemic Optic Neuropathy
  • Philadelphia, Pennsylvania
    Neuro-Ophthalmologic Associates, PC
Jan 22, 2016

Cognitive Fatigue Trial in London (Fampridine SR, Placebo)

Completed
  • Cognitive Fatigue
  • Fampridine SR
  • Placebo
  • London, Ontario, Canada
    London Health Sciences Center and St. Joseph's Heathcare Center
Sep 1, 2015

Lambert Eaton Myasthenic Syndrome (LEMS) Trial in New York (3,4-diaminopyridine)

No longer available
  • Lambert Eaton Myasthenic Syndrome (LEMS)
  • New York, New York
    Columbia University Medical Center
Jul 17, 2013

Multiple Sclerosis Trial in Creteil, Paris, Rennes (3,4-diaminopyridine)

Completed
  • Multiple Sclerosis
  • Creteil, France
  • +3 more
Feb 18, 2011

Multiple Sclerosis, Fatigue Trial in Aarhus (3,4-diaminopyridine, Placebo)

Completed
  • Multiple Sclerosis
  • Fatigue
  • Aarhus, Denmark
    Aarhus University Hospital, Department of Neurology
Dec 12, 2007

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial (,4-diaminopyridine)

Completed
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  • (no location specified)
Jun 23, 2005